[Diagnosis Name]

CP is diagnosed clinically based on the presence of a non-progressive neurodevelopmental motor disorder arising from an early brain injury. Diagnosis is established in childhood — the hospice clinician encounters a patient with a decades-old confirmed diagnosis, not an undiagnosed condition.

• MRI brain: Documents the type and location of the causative brain injury. Periventricular leukomalacia (PVL) is the most common pattern in premature infants — white matter signal abnormality on T2 sequences in the periventricular regions. Cortical/subcortical injury patterns produce mixed or spastic quadriplegia. Basal ganglia and thalamic injury produces dyskinetic CP (athetosis, choreoathetosis). Cerebellar injury produces ataxic CP.
• GMFCS level (I–V): Gross Motor Function Classification System — the international standard for motor severity. Hospice population is GMFCS IV or V. Document the GMFCS level explicitly at enrollment — it is the primary determinant of prognosis, care burden, and hospice eligibility.^[3]
• Motor type classification: Spastic (most common — 70–80% of CP; upper motor neuron pattern with velocity-dependent increased tone); Dyskinetic (basal ganglia injury; involuntary movements — athetosis, dystonia, chorea); Ataxic (cerebellar injury; coordination and balance dysfunction); Mixed (most common in severe CP — spastic with dystonic features).^[13]
• Topographic distribution: Quadriplegia (all four limbs — most common in GMFCS IV–V); diplegia (predominantly lower limbs); hemiplegia (one side); triplegia (three limbs).
• CFCS level (I–V): Communication Function Classification System — documents communication functional severity. CFCS Level I = effective communicator with unfamiliar and familiar partners. CFCS Level V = seldom effectively communicates even with familiar partners. Critical for care planning and for honoring the preserved cognition that may exist behind CFCS IV–V communication impairment.^[12]

• Level I: Walks without limitations. Runs, climbs stairs. Not hospice population.
• Level II: Walks with limitations. Difficulty on uneven terrain, stairs. Not hospice population.
• Level III: Walks using handheld mobility device (walker, crutches). Difficulty outdoors. Not hospice population.
• Level IV: Self-mobility with limitations. Uses powered wheelchair or is pushed in manual wheelchair. Sits with support. May be in hospice population if multiple systems involved.
• Level V: Transported in manual wheelchair. No independent mobility. Cannot maintain head or trunk position against gravity without extensive support. Cannot self-propel in any power wheelchair even with modified controls. Primary hospice population for severe CP. Total dependence for all mobility, positioning, personal care, transfers. Cannot voluntarily control upper or lower extremities for purposeful movement.^[3]

GMFCS V at age 40+ with recurrent aspiration pneumonia, declining pulmonary reserve, or caregiver system failure = hospice-appropriate clinical profile. The GMFCS level must be documented at enrollment — it is the foundation of every eligibility and prognosis discussion.^[4]

At enrollment, the clinical record must document the following elements to establish hospice eligibility and create a safe care plan for a patient with severe CP:

• GMFCS level: Documented explicitly (not implied). Level IV or V for hospice-appropriate severe CP.
• Primary motor type and topographic distribution: Spastic quadriplegia (most common), dyskinetic quadriplegia, mixed. Documents the clinical basis for spasticity management.
• Cognitive and communication status: Intellectual disability — none, mild, moderate, severe, profound (IQ or developmental equivalent if available); communication modality — speech (any functional speech?), AAC device (what type? mounted where? who programs it?), gestural/behavioral communication (what are the specific signals for yes, no, pain, comfort, discomfort?). Document the primary caregiver's interpretation of the patient's communication signals.^[12]
• Seizure disorder — present or absent: Document seizure type (focal, generalized, mixed), frequency at baseline, last seizure date, and breakthrough seizure history. Document the current anticonvulsant regimen with doses.
• Spasticity management regimen: Current medications (oral baclofen dose; diazepam dose; tizanidine dose; clonidine dose); intrathecal baclofen pump (present or absent — see below); botulinum toxin history (last injection date, which muscles, which center).
• Gastrostomy tube: Type (PEG vs. MIC-KEY low-profile button), tube size (French size), date of placement, current formula (brand, concentration, rate in mL/hr or mL per feeding), feeding schedule (bolus vs. continuous), tolerance (residuals, reflux, vomiting frequency).
• GERD management: PPI agent and dose (omeprazole, pantoprazole, lansoprazole); H2 blocker if dual therapy; positioning (head of bed elevation, semi-reclined positioning post-feed); documented aspiration events related to reflux.

For patients with an intrathecal baclofen (ITB) pump, the pump interrogation record is the most critical clinical document at enrollment. Obtain it before the end of the first visit — if it is not in the chart, call the implanting center before leaving.

• Pump model and serial number: Required for troubleshooting and replacement. Document the pump brand (Medtronic SynchroMed II most common) and model number.
• Programmed basal rate: Current daily dose in micrograms per day (mcg/day). Common range is 100–1000 mcg/day for severe CP — document the exact programmed dose.
• Bolus doses: Are patient-activated or scheduled boluses programmed? If so, document the bolus dose, frequency, and lockout interval.
• Current drug reservoir volume: In mL — document the volume confirmed at last refill or last interrogation.
• Last refill date: Document the date of last refill.
• Projected empty date: Calculate from reservoir volume and daily dose (reservoir volume ÷ daily rate = days remaining). This date must be in the care plan as prominently as the next physician visit.
• Catheter tip location: Typically T6–T10 thoracic level. Documents the distribution of intrathecal baclofen delivery.
• Alarm history: Any prior motor stall, low reservoir, end-of-service, or communication error alarms. Prior alarms predict future alarm risk.^[14][15]
• Managing center contact: The clinic responsible for pump management — neurosurgery or physiatry. Document the specific provider, clinic phone, and after-hours emergency contact number for pump emergencies.

The periventricular white matter (PVWM) is the anatomical target most vulnerable to injury in premature infants — the most common pathway to severe spastic CP:

• Developmental vulnerability window: The oligodendrocyte precursor cells (pre-OLs) that populate the PVWM at 23–32 weeks gestational age are exquisitely sensitive to hypoxic-ischemic and inflammatory injury. These are the cells that will eventually myelinate the corticospinal tracts — the motor pathways from cortex to spinal cord that control voluntary movement.
• Periventricular leukomalacia (PVL): White matter injury at the PVWM produces PVL — visible on MRI as periventricular T2 signal abnormality, cystic changes, or volume loss. PVL disrupts the corticospinal tracts bilaterally, producing the spastic quadriplegia or spastic diplegia that characterizes most severe CP.
• Causes: Premature birth (especially <28 weeks GA); perinatal hypoxia-ischemia; intrauterine infection and maternal chorioamnionitis (inflammatory cytokines directly injure pre-OLs); placental insufficiency; twin-to-twin transfusion syndrome; periventricular hemorrhage with white matter extension.^[8][16]
• Clinical implication for hospice: The bilateral corticospinal tract disruption that PVL produces explains the bilateral spasticity of all four limbs that drives contractures, hip dislocation, scoliosis, and the windswept deformity — the musculoskeletal burden that creates the pain management imperative in severe adult CP at end of life.

• Basal ganglia and thalamic injury (perinatal asphyxia): Term or near-term hypoxic-ischemic encephalopathy (HIE) from acute severe asphyxia at birth produces selective vulnerability of the basal ganglia and thalamus. This produces dyskinetic CP — characterized by involuntary, uncontrolled movements (athetosis, dystonia, choreoathetosis) rather than the spasticity of PVL-pattern CP. Dystonia in end-stage dyskinetic CP produces continuous involuntary movement, severe pain from sustained abnormal postures, and extraordinary energy expenditure — caloric needs are dramatically elevated and malnutrition is a constant clinical challenge.
• Cortical and subcortical injury: Focal or diffuse cortical injury from stroke, infection (TORCH infections — toxoplasmosis, rubella, CMV, herpes), metabolic encephalopathy, or hypoglycemia. May produce mixed spastic-dyskinetic pattern with variable intellectual disability depending on extent of cortical involvement.
• Cerebellar injury: Produces ataxic CP — the least common type. Coordination, balance, and fine motor dysfunction. Less likely to produce the severe spasticity and contracture burden of spastic quadriplegia, but dysarthria and dysphagia remain significant aspiration risks.^[8][13]
• Postnatal injury (up to age 2–3 years): Meningitis, encephalitis, traumatic brain injury, near-drowning, or severe hypoglycemia during the early postnatal period before the period of brain plasticity closes. Produces acquired CP with the same clinical phenotype as congenital CP.

• The spasticity mechanism: Upper motor neuron (UMN) injury produces a velocity-dependent increase in muscle tone — the muscle that is stretched quickly resists movement abnormally. In CP, UMN injury is bilateral and involves the corticospinal tracts, producing this velocity-dependent hypertonicity in all four limbs (in quadriplegia).
• Chronic spasticity → muscle shortening: The spastic muscle that is chronically contracted never achieves its full resting length. Over years, permanent sarcomere loss occurs within the muscle fibers, and connective tissue remodeling (fibrosis of the muscle-tendon unit) produces a muscle that physically cannot extend to its normal length even under anesthesia — the fixed contracture. By adulthood in severe CP, contractures of hip flexors, hip adductors, knee flexors, equinus deformity of the ankles, and elbow flexors are universally present and are fixed — they cannot be reversed by any intervention at end stage.
• Pain from contractures: The contracted joint that is forced toward its anatomical neutral position during positioning, transfers, bathing, and personal care causes severe pain. Pre-procedure analgesia is required before every care task that involves moving contracted limbs.^[17][19]
• Windswept deformity: Asymmetric spasticity and hip position produce the characteristic lower extremity posture — one hip abducted and externally rotated, the contralateral hip adducted and internally rotated — with the legs appearing swept to one side of midline. This posture, when combined with pelvic obliquity, makes pressure-equalizing positioning technically demanding and requires specialty seating assessment.

• Hip dislocation mechanism: The spastic hip adductors and flexors pull the femoral head medially and anteriorly out of the acetabulum. This process begins in early childhood and is progressive if untreated. Hip dislocation rates in GMFCS V CP approach 50–90% — the majority of adults with severe quadriplegic CP have subluxed or fully dislocated hips. The dislocated hip causes severe pain during any movement of the hip joint — during repositioning, transfers, bathing, perineal care, and passive range of motion. This pain is expressed behaviorally in non-verbal patients and is frequently mislabeled as "agitation."^[20]
• Scoliosis: Asymmetric trunk muscle tone from bilateral but asymmetric spasticity produces spinal curvature. In GMFCS V CP, scoliosis is nearly universal — curves exceeding 60° Cobb angle are common by adulthood. Severe scoliosis restricts respiratory expansion (exactly as in DMD), compounds the aspiration pneumonia risk, and produces the same respiratory-scoliosis interaction that is the terminal mechanism in other neuromuscular diagnoses. Spinal fusion (if performed in adolescence) stabilizes the curve but does not restore lost lung volume — the adult with a fused thoracolumbar curve may have significantly restricted total lung capacity.
• Pelvic obliquity: Asymmetric hip forces and scoliosis combine to produce pelvic obliquity — tilting of the pelvis in the frontal plane. Pelvic obliquity creates focal pressure concentration under the elevated ischial tuberosity, dramatically increasing pressure injury risk.
• Positioning impossibility: The combination of fixed contractures, windswept deformity, hip dislocation, scoliosis, and pelvic obliquity makes neutral comfortable positioning anatomically impossible without custom seating and positioning systems. Standard bed positioning and standard wheelchair seating cause pressure injury and pain in this population. Specialty seating consultation is a medical necessity, not a luxury.^[21]

The ITB pump delivers baclofen directly to the intrathecal space at the level of the spinal cord — producing spasticity reduction at doses 100–1000× lower than equivalent oral doses. The pump is the primary — often the only effective — spasticity management for GMFCS IV–V CP patients. Abrupt cessation of intrathecal baclofen produces baclofen withdrawal syndrome, a life-threatening medical emergency.

• Baclofen withdrawal syndrome clinical features: Onset within 24–72 hours of cessation. Progressive return of spasticity → severe rebound spasticity far exceeding pre-pump baseline → hyperthermia → autonomic instability (tachycardia, diaphoresis, hypertension) → rhabdomyolysis → multi-organ failure → death. The clinical picture resembles malignant hyperthermia and neuroleptic malignant syndrome.
• Mortality: Baclofen withdrawal syndrome has a reported mortality of 5–10% even with aggressive management. In a hospice patient who is already at the threshold of cardiorespiratory reserve, withdrawal syndrome is very likely fatal.^[14][15]

Five-Step ITB Pump Protocol at Hospice Enrollment:

• Step 1: Obtain pump interrogation record at first visit — model, basal rate (mcg/day), reservoir volume, last refill date, catheter tip location, alarm history, managing center contact.
• Step 2: Calculate projected empty date (reservoir volume ÷ daily rate in mL/day). Document this date prominently in the care plan.
• Step 3: If prognosis is weeks and refill date falls within that window, initiate the advance directive discussion proactively: does the patient/proxy want the pump refilled? If not, pre-position the oral comfort bridge BEFORE the pump empties.
• Step 4: If any alarm is active (motor stall, low reservoir, end-of-service, communication error), contact the implanting center same day. An unaddressed alarm can progress to pump failure within hours to days.
• Step 5: Educate every caregiver: any pump alarm = call the hospice nurse immediately — do not wait. Document the alarm response protocol in the care plan.^[14]

The refill decision: The ITB pump refill requires a clinic visit to the implanting center. For a patient who is imminently dying, this visit adds significant burden. The decision must be made proactively — not during a withdrawal crisis.

• If refilling: Coordinate with the implanting center to accommodate the patient's condition (home visit by the pump clinic if possible; minimize transport burden; pre-medicate for transport pain).
• If not refilling (patient/proxy decision): Pre-position the oral baclofen bridge BEFORE the pump empties. This is not optional — it is the clinical obligation that replaces the refill decision. The bridge must be in place before the reservoir is empty.^[15]

Oral Baclofen Bridge Protocol (ITB Pump Running Down):

• Oral baclofen 20–80 mg/day in divided doses (TID–QID): The intrathecal-to-oral conversion requires substantially higher oral doses because oral bioavailability at the spinal cord is dramatically lower than intrathecal delivery. The dose required to partially replace the intrathecal effect is 50–100× higher than the mcg/day intrathecal dose. Start with oral baclofen 20 mg TID and titrate upward aggressively as the pump reservoir depletes. Maximum recommended oral dose is approximately 80 mg/day, but higher doses may be required in some patients — sedation is the dose-limiting side effect.^[15]
• Diazepam 5–10 mg TID–QID: Addresses the acute spasm component and the anxiety/agitation of withdrawal onset. Provides sedation that is appropriate in the comfort-focused context.
• Clonidine 0.1–0.3 mg BID: Alpha-2 agonist with anti-spasticity properties; addresses autonomic instability component of withdrawal.
• Continuous subcutaneous midazolam infusion: If oral bridge is insufficient to control rebound spasticity and autonomic instability, escalate to continuous benzodiazepine infusion via CSCI.
• Advance directive documentation: The decision to allow the pump to run down without refill must be explicitly documented in the advance directive, with the withdrawal bridge protocol co-documented as the comfort plan.

Aspiration pneumonia in severe CP is not a single crisis — it is a recurring clinical pattern. Each event must be anticipated, not discovered. The advance directive for aspiration pneumonia must be completed at enrollment — before the next pneumonia event creates a crisis decision context.

• Hospitalization preference: Document explicitly: (a) hospitalization for IV antibiotics and respiratory support with intent to return to baseline; (b) home-based management with oral antibiotics (if patient can tolerate enteral medications) or comfort-directed IV antibiotics via PICC; (c) comfort-only management — symptom management without antibiotics, prioritizing comfort over infection treatment. Most hospice patients with severe CP who have had multiple pneumonia events and declining baseline pulmonary function are appropriate for option (b) or (c) — but this must be the advance directive decision of the patient/proxy, not the default clinical response.
• Antibiotic preference at comfort level: Comfort-directed antibiotic therapy (oral amoxicillin-clavulanate or azithromycin for aspiration pneumonia in the home setting) reduces fever and dyspnea without requiring hospitalization. Evidence supports that antibiotics in the palliative context improve symptom burden even when cure is not the goal.^[28]
• Oral hygiene as primary prevention: Daily meticulous oral hygiene with chlorhexidine 0.12% reduces oral bacterial colonization and decreases aspiration pneumonia incidence. Evidence from randomized trials in nursing home residents supports this as primary aspiration pneumonia prevention.^[29]
• Recognition of terminal pneumonia event: The pneumonia event that does not respond to appropriate antibiotic therapy, that produces worsening respiratory distress despite treatment, or that occurs in the context of global functional decline to PPS ≤20% — is the terminal event. Document that the family understands this possibility at enrollment so that the recognition of the terminal event is supported by prior conversations, not made in crisis.

• Mechanical suctioning: Suction equipment must be in the home and family/caregiver must be trained and competent. Document suction frequency, catheter size, suction pressure, and caregiver comfort with the procedure. For patients with abundant oral secretions, suction frequency may be every 30–60 minutes during waking hours. Yankauer rigid suction catheter for oral suctioning; soft French catheter for nasopharyngeal suctioning if needed.
• Oral hygiene protocol: Twice-daily tooth brushing with a soft-head toothbrush and small-head design accommodating reduced mouth opening. Chlorhexidine 0.12% oral rinse (applied via soft swab or foam stick if patient cannot rinse and spit) — evidence supports chlorhexidine oral hygiene for aspiration pneumonia prevention.^[29]
• Secretion-reducing medications: Glycopyrrolate 1–2 mg TID PO (via GT) or 0.1–0.2 mg SC/IV — antimuscarinic with reduced CNS penetration compared to scopolamine; preferred first-line for secretion reduction. Hyoscine hydrobromide (scopolamine) patch 1.5 mg/72h — alternative for transdermal delivery when GT route is not tolerated. Atropine 1% ophthalmic drops 1–2 drops SL PRN for acute secretion management (off-label but well-established hospice practice).
• Positioning for aspiration reduction: Head of bed elevated 30–45° at minimum. Semi-reclined positioning in wheelchair. Avoid supine positioning immediately after GT feeds — maintain upright for at least 30–60 minutes post-feed. Semi-prone positioning during sleep if tolerated may reduce aspiration of oral secretions.

Pain is substantially underrecognized and undertreated in non-verbal adults with CP. The primary reason is the absence of verbal self-report and the attribution of behavioral pain signals to "agitation," "behavioral problems," or "baseline behavior." A systematic behavioral pain assessment framework is required at every visit.

• Non-Communicating Children's Pain Checklist — Postoperative Version (NCCPC-PV): The most validated behavioral pain scale for individuals with cognitive impairment and CP. 27-item scale assessing vocal, social, facial, activity, body/limbs, and physiologic domains. Scores of 7 or above indicate clinically significant pain requiring treatment response. Although originally validated in children, clinical evidence and expert consensus support application in adults with CP and intellectual disability.^[26]
• Caregiver-individualized behavioral pain indicators: The NCCPC-PV provides population-level behavioral indicators. The primary caregiver's individualized behavioral indicators for this specific patient — developed over decades of direct observation — are more sensitive and specific. At enrollment, ask: "Show me what pain looks like in your person." Document those exact behaviors in the care plan as the primary pain recognition standard for this individual. Post them where every aide, nurse, and visitor can see them.
• Pain assessment at every nursing visit: Document the NCCPC-PV score at every nursing visit. Track trends. A rising NCCPC-PV score that is not explained by a new acute event (infection, constipation, skin breakdown) may indicate worsening spasticity requiring dose adjustment, hip dislocation pain progression, or GERD exacerbation.
• Treat pain before treating "agitation": Any PRN benzodiazepine order written for "agitation" must be preceded by NCCPC-PV assessment. If the score is ≥7, the clinical obligation is to treat pain — not to sedate the expression of pain. Prescribe an analgesic first.^[26][27]

• Pre-procedure analgesia — standing order for all personal care: The patient with hip dislocation and fixed contractures experiences severe pain with every repositioning, transfer, bath, and perineal care event. A standing pre-procedure analgesic order must be written at enrollment: opioid (oral morphine 5–15 mg via GT or oxycodone 5–10 mg via GT) 30–45 minutes before any care task involving movement of the hips, adductor stretching, or position change. This is not PRN — it is pre-procedure protocol.^[27]
• Scheduled opioid therapy for persistent pain: For patients with documented continuous moderate-to-severe pain (NCCPC-PV ≥7 at rest or at multiple visits), initiate scheduled opioid therapy: oral morphine 5–10 mg every 4 hours via GT, titrating to comfort. PRN breakthrough dose: 25–33% of the scheduled 4-hour dose every 2 hours as needed.
• Non-opioid adjuncts for spasticity-related pain: Gabapentin 100–400 mg TID via GT (neuropathic/central pain component of spasticity); diazepam 2–10 mg TID (antispasticity and anxiolytic); clonidine 0.1–0.2 mg BID (alpha-2 agonist antispasticity adjunct).
• Do NOT force range of motion: The contracted joint that has been in fixed position for decades cannot be forced into extension without causing pain and potential fracture. The positioning goal at end stage is to accommodate the contracture comfortably — not to reverse it. Passive range of motion applied aggressively to end-stage CP contractures is iatrogenic harm.
• TENS or topical heat for localized spasm: Transcutaneous electrical nerve stimulation (TENS) applied to the paraspinal muscles or upper limbs may reduce localized spasm pain. Topical heat (heating pad at lowest setting, with skin checks to prevent thermal injury in insensate areas) provides adjunct comfort.^[19]

• Specialty seating assessment at enrollment: Request physical therapy (PT) and assistive technology specialist assessment for wheelchair seating and bed positioning system adequacy. Standard wheelchair seating systems do not accommodate windswept deformity, pelvic obliquity, and severe scoliosis simultaneously. Custom-molded seating systems with lateral trunk supports, hip guides, and pelvic positioning belts are required for pressure equalization and postural support in severe CP.^[21]
• Pressure injury prevention: The combination of pelvic obliquity, contracture, and malnutrition creates extremely high pressure injury risk. Pressure mapping assessment of the wheelchair seating interface documents focal pressure concentration points. Gel or air-fluid seat cushions with pressure-redistribution properties are first-line. Turn schedule in bed: repositioning every 2 hours minimum; more frequently if skin integrity is already compromised.
• Bed positioning system: Custom foam positioning wedges, body pillows, and cushions to maintain the patient in the asymmetric posture dictated by their contractures — not to force symmetry. Work with what the body currently is — accommodate the windswept deformity, support the scoliotic spine, use enough padding to offload bony prominences.
• Scoliosis and respiratory implications: Severe scoliosis (Cobb angle >60°) significantly restricts chest wall expansion and reduces effective tidal volume. This compounds the aspiration pneumonia risk and the impaired airway clearance. Positioning in a semi-reclined, slightly lateral posture may improve respiratory mechanics compared to fully upright in a severe scoliotic patient.

• Determine hip dislocation status at enrollment: Review imaging history for documented hip subluxation or dislocation. Ask the caregiver: "Does repositioning or any hip movement cause a pain response?" If yes, assume hip dislocation pain is contributing to the behavioral distress that has been attributed to "agitation."
• No passive range of motion to dislocated hips: Do not attempt to bring the dislocated hip toward neutral. Do not apply adductor stretching beyond the pain-free range. Do not perform passive hip extension. The dislocated hip in a 45-year-old with severe CP cannot be reduced without surgical intervention — which is not the goal at end stage. The goal is to position the hip in its current location with maximal comfort.
• Pre-procedure analgesia as standing order: Opioid pre-medication 30–45 minutes before ALL care tasks involving hip movement (diaper changes, catheter care, repositioning from side to side, transfers to/from wheelchair). This is a standing order — not a PRN — because these tasks happen multiple times daily.^[20]
• Heat application for localized spasm relief: Moist heat (warm towel, not hot pad — check for impaired sensation before applying) to the hip girdle musculature 15–20 minutes before care tasks may reduce spasm-related pain. Never apply direct heat to insensate areas without skin temperature check.
• Orthopaedic consultation: In select cases where hip pain is the dominant uncontrolled symptom and cannot be managed medically, palliative orthopaedic consultation for femoral head resection (Girdlestone procedure) or femoral head resection arthroplasty may reduce hip dislocation pain substantially — even in the hospice context, if prognosis is months and pain is severe. Document this option in the care plan as a consideration.^[20]

The parent of a person with severe CP has been grieving since the day of diagnosis. This is chronic sorrow — the grief that comes not from a single loss but from an unbroken series of smaller losses across a lifetime: the first steps that never happened, the first day of school that looked nothing like anyone expected, the medical crises that each felt like a possible last. Chronic sorrow in CP caregivers is well-documented and is distinct from clinical depression — it is an adaptive, episodic experience of grief that does not resolve but recurs whenever a milestone or expectation is encountered.^[50]

• Social work opening question: "What have these 45 years been like? What have you learned about your child that no one else in the world knows?" — this question provides acknowledgment and elicits the intimacy and knowledge that is the caregiver's most precious resource
• Assess for complicated grief: Prolonged grief disorder occurs in approximately 10–15% of caregivers of adults with complex disability — screen using the Brief Grief Questionnaire or PG-13 scale
• Validate the grief as legitimate: Many caregivers report that family and professionals minimized their grief over decades because their child was alive; name it explicitly as real grief that deserves real support

The 70-year-old mother who has provided full-body care for 45 years does not have a self that exists independently of caregiving. It is not hyperbole. The daily structure of her life — the 5 AM feed, the morning repositioning, the medication schedule, the afternoon suctioning, the evening bath — is the architecture of her identity. When her child dies, that architecture collapses.^[51]

• Bereavement planning begins before death: Ask the caregiver about who she is outside of caregiving. What did she do before? What does she imagine for herself after? The question itself begins the process.
• Connect to caregiver support group before death: CP family caregiver networks, aging parent support groups — connection before the death is easier and more effective than referral after
• Assess for social isolation: Many CP primary caregivers have given up friendships, career, and their own medical care over decades of total commitment; the social isolation after death can be profound and dangerous
• Hospice bereavement plan must begin at enrollment: Document the primary caregiver as a high-risk bereavement case requiring structured follow-up — not a generic 13-month bereavement letter

A significant subset of adults with severe motor involvement in CP have fully intact or near-intact cognition — intact intelligence, personality, emotional life, and awareness — but have been communicated with as if cognitively impaired throughout their medical history because clinicians conflated the severity of motor involvement with cognitive status. This is one of the most serious and most common clinical errors in CP care. At hospice enrollment, cognitive status must be independently assessed — not assumed from the GMFCS level or the presence of severe spasticity.^[53]

• The CFCS (Communication Function Classification System) documents communication functional level independently of motor severity — a GMFCS V patient may be CFCS I (effective communicator with familiar and unfamiliar partners) or CFCS V (seldom effectively communicates even with familiar partners); these are not the same clinical situation
• Ask the caregiver directly: "Does she understand what people say to her?" — the caregiver's answer is often more accurate than any formal assessment
• Observe for receptive language indicators: Does the patient respond differentially to familiar versus unfamiliar voices? Does emotional expression shift in response to content of conversation?
• Consult the AAC team: If there is any evidence of preserved cognition, augmentative and alternative communication (AAC) assessment should be completed at enrollment — not deferred

The fully cognitively intact adult with severe CP who has been communicated with as if impaired throughout a lifetime of medical care has experienced a specific and profound injustice. In the hospice context, the communication imperative is immediate and urgent: this person must be addressed directly, informed of their situation, included in goals-of-care discussions, and given every available means to express their wishes.^[53]

• Address the patient directly, not through the caregiver: "I'm going to ask you some questions and I'm going to listen for your response in whatever way you communicate" — then do exactly that
• Use yes/no scaffolding: Ask questions that can be answered with eye blink, thumb movement, any reliable motor signal — document the communication system and teach every team member
• Assumed competence as the default: In the absence of clear evidence of cognitive impairment, assume competence and communicate accordingly; the harm of assuming competence in someone who is not is minimal; the harm of assuming incompetence in someone who is fully aware is devastating
• Goals-of-care with the patient directly: If the patient can communicate by any means, the goals-of-care conversation belongs with the patient first — not exclusively with the proxy

Standard verbal depression screening tools cannot be used with non-verbal patients. Behavioral indicators of depression and anxiety in severe CP — increased withdrawal from previously enjoyed stimuli, changes in sleep-wake patterns observed by caregiver, reduced responsiveness to familiar voices, increased agitation or crying without clear pain etiology — must be assessed through caregiver-report and behavioral observation.^[55]

• Ask the caregiver: "Have you noticed any changes in her mood or behavior recently? Does she seem more withdrawn, more agitated, or less responsive to things she used to respond to?" — the caregiver is the most sensitive behavioral assessment instrument available
• Behavioral distress that is not explained by pain: If behavioral pain assessment (NCCPC-PV score <6) does not explain agitation, consider depression and anxiety as differential; trial of mirtazapine 7.5 mg QHS may address mood, sleep, and appetite simultaneously
• Music and sensory engagement as assessment and intervention: Does the patient respond to music the caregiver identifies as familiar and comforting? Reduced response to previously enjoyed stimuli is a behavioral marker of depression and a target for intervention

The 70-year-old caregiver of an adult with severe CP is at elevated risk for suicidal ideation — not the passive "I'm ready to go" of the hospice patient, but the active ideation of a person who is physically broken, socially isolated, and facing the loss of the only role that has given her life meaning for 45 years. This screening must happen. It will not happen if the clinician does not ask.^[56]

• Ask directly: "Taking care of someone this intensely for this long takes a profound toll. Some caregivers reach a point where they have thoughts of not wanting to go on — have you had any thoughts like that?" — directness does not increase risk; it opens the door
• Distinguish passive ideation from active plan: Passive wish to die (very common in exhausted caregivers) requires acknowledgment, support referral, and increased check-in frequency; active ideation with plan requires immediate psychiatric engagement and safety planning
• Caregiver suicide risk factors specific to CP: Complete social isolation; physical injury (back, shoulders) from caregiving; history of inadequately treated depression; expressed feeling that no one else can care for the patient adequately; financial devastation from 45 years of caregiving costs
• Document and follow: Screen at enrollment and at every nursing visit; caregiver emotional status is a patient safety issue — if the caregiver decompensates, the patient has no care

• The parent as proxy: The 70-year-old mother who is the primary caregiver is almost always the legal proxy decision-maker; she knows this patient's preferences better than any clinical tool can capture; treat her as the expert she is, while also assessing whether her own grief and exhaustion are influencing her decisions in ways she may not recognize
• Substituted judgment vs. best interest: Proxy decision-making in CP should prioritize substituted judgment (what would this person want, based on known values and preferences) over best interest (what does the medical team think is optimal); for patients with long-standing preferences expressed through behavior, the caregiver's knowledge of those preferences is the primary evidence base^[58]
• Goals-of-care opening: "What do you understand about where things stand with [patient name]'s health? What matters most to her — based on everything you know about who she is?"
• Do not conflate caregiver guilt with patient preferences: A caregiver who says "I don't want her to suffer but I also can't let her go" is telling you about her own grief, not her child's preferences; hold space for both simultaneously

The person with severe CP who has lived at home for 45 years — who has been cared for in the same bedroom, by the same person, with the same routines — deserves to die at home if the caregiver can sustain it. This is not a neutral clinical question. It is a justice question. The caregiver who can no longer safely provide care alone should be supported to maintain the home death — not defaulted to facility placement because the hospice team did not arrange adequate aide support.^[51]

• Maximize hospice aide hours proactively: Do not wait for caregiver capacity to fail; arrange maximum available aide hours at enrollment and reassess weekly
• Continuous home care eligibility: When the patient enters the active dying phase or when caregiver capacity is acutely threatened, continuous home care (CHC) provides 8–24 hours of nursing or aide presence in the home — document the clinical indication proactively
• Inpatient respite care: Five days of inpatient respite allows the caregiver to rest; offer this proactively, not only when crisis arrives
• Plan for the death itself: Discuss with the caregiver what she wants the moment of death to look like; who should be present; what music or readings; the 70-year-old who has been present for every moment of her child's life deserves to be present for the last one, supported and not alone